Fine RL - Search Results

1

Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: feasibility, efficacy, and survival.

Allendorf JD, Lauerman M, Bill A, DiGiorgi M, Goetz N, Vakiani E, Remotti H, Schrope B, Sherman W, Hall M, Fine RL, Chabot JA. Allendorf JD, et al. Among authors: fine rl. J Gastrointest Surg. 2008 Jan;12(1):91-100. doi: 10.1007/s11605-007-0296-7. Epub 2007 Sep 5. J Gastrointest Surg. 2008. PMID: 17786524

2

Combination gemcitabine and docetaxel therapy in advanced adenocarcinoma of the pancreas.

Sherman WH, Fine RL. Sherman WH, et al. Among authors: fine rl. Oncology. 2001;60(4):316-21. doi: 10.1159/000058527. Oncology. 2001. PMID: 11408799

3

Advances in the Genetic Screening, Work-up, and Treatment of Pancreatic Cancer.

Frucht H, Stevens PD, Fogelman DR, Verna EC, Chen J, Chabot JA, Fine RL. Frucht H, et al. Among authors: fine rl. Curr Treat Options Gastroenterol. 2004 Oct;7(5):343-354. doi: 10.1007/s11938-004-0047-8. Curr Treat Options Gastroenterol. 2004. PMID: 15345205

4

The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTX.

Fogelman DR, Chen J, Chabot JA, Allendorf JD, Schrope BA, Ennis RD, Schreibman SM, Fine RL. Fogelman DR, et al. Among authors: fine rl. Surg Oncol Clin N Am. 2004 Oct;13(4):711-35, x. doi: 10.1016/j.soc.2004.06.005. Surg Oncol Clin N Am. 2004. PMID: 15350944 Review.

5

The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis.

Fine RL, Fogelman DR, Schreibman SM, Desai M, Sherman W, Strauss J, Guba S, Andrade R, Chabot J. Fine RL, et al. Cancer Chemother Pharmacol. 2008 Jan;61(1):167-75. doi: 10.1007/s00280-007-0473-0. Epub 2007 Apr 18. Cancer Chemother Pharmacol. 2008. PMID: 17440727

6

Mutational analyses of multiple oncogenic pathways in intraductal papillary mucinous neoplasms of the pancreas.

Schönleben F, Allendorf JD, Qiu W, Li X, Ho DJ, Ciau NT, Fine RL, Chabot JA, Remotti HE, Su GH. Schönleben F, et al. Among authors: fine rl. Pancreas. 2008 Mar;36(2):168-72. doi: 10.1097/MPA.0b013e318158a4d2. Pancreas. 2008. PMID: 18376308 Free PMC article.

7

Head and neck squamous cell carcinoma in FAMMM syndrome.

Vinarsky V, Fine RL, Assaad A, Qian Y, Chabot JA, Su GH, Frucht H. Vinarsky V, et al. Among authors: fine rl. Head Neck. 2009 Nov;31(11):1524-7. doi: 10.1002/hed.21050. Head Neck. 2009. PMID: 19360740

8

Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer.

Chabot JA, Tsai WY, Fine RL, Chen C, Kumah CK, Antman KA, Grann VR. Chabot JA, et al. Among authors: fine rl. J Clin Oncol. 2010 Apr 20;28(12):2058-63. doi: 10.1200/JCO.2009.22.8429. Epub 2009 Aug 17. J Clin Oncol. 2010. PMID: 19687327 Free PMC article. Clinical Trial.

9

Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor.

Thearle MS, Freda PU, Bruce JN, Isaacson SR, Lee Y, Fine RL. Thearle MS, et al. Among authors: fine rl. Pituitary. 2011 Dec;14(4):418-24. doi: 10.1007/s11102-009-0211-1. Pituitary. 2011. PMID: 19960369 Free PMC article.

10

Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.

Verna EC, Hwang C, Stevens PD, Rotterdam H, Stavropoulos SN, Sy CD, Prince MA, Chung WK, Fine RL, Chabot JA, Frucht H. Verna EC, et al. Among authors: fine rl. Clin Cancer Res. 2010 Oct 15;16(20):5028-37. doi: 10.1158/1078-0432.CCR-09-3209. Epub 2010 Sep 28. Clin Cancer Res. 2010. PMID: 20876795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters